arrow
J

Jaime Sanz

university hospital la fe
H指数:42
被引数:6,351

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT

更正:与含移植后环磷酰胺的错配无关供者异基因移植相比,T细胞充足型半相合移植在二次急性髓系白血病首次完全缓解患者中的研究:ALWP/EBMT研究

2026-11-050
OAAI
Lung transplantation after allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT

同种异基因造血干细胞移植后的肺移植:EBMT移植并发症工作组的研究

2026-10-260
PRE
Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC

25岁以下复发/难治性B-ALL儿科及青少年成年过渡期患者接受抗CD19 CAR-T治疗时的桥接治疗:西班牙GETH-TC多中心回顾性研究

2026-10-120
PRE
GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis

GVHD的预防与发生情况:当代alloHSCT下的大规模真实世界GETH/TC分析

2026-09-170
PRE
Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT

异基因干细胞移植联合移植后环磷酰胺治疗急性髓系白血病患者:单次诱导与两次诱导后达到首次完全缓解的对比研究——来自ALWP/EBMT的研究

2026-09-020
OAAI
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

更正:费城染色体阳性急性淋巴细胞白血病合并附加细胞遗传学异常的移植结局:欧洲血液与骨髓移植学会急性白血病工作组的研究

2026-08-310
OAAI
Redefining Engraftment Syndrome After Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantation: A Novel Classification and Impact on Outcomes

移植后环磷酰胺异基因造血细胞移植后植入综合征的重新定义:一种新的分类及其对预后的影响

2026-08-010
PRE
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

异基因HSCT后成人患者发生SOS/VOD的发病率、临床危险因素及生物标志物。西班牙HSCT与细胞治疗工作组(GETH-TC)的真实世界研究。

2026-07-170
PRE
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities

携带附加细胞遗传学异常的费城染色体阳性急性淋巴细胞白血病的移植结果

2026-07-130
OAAI
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

T细胞富集的半相合移植与使用移植后环磷酰胺的错配无关供者异基因移植治疗首次完全缓解期继发性急性髓系白血病患者的比较:一项来自ALWP/EBMT的研究

2026-06-270
OAAI
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee

当代造血细胞移植中的HLA配型:EBMT实践协调与指南委员会的建议

2026-06-020
OAAI
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT

混合表型急性白血病患者接受异基因造血干细胞移植的结局:EBMT ALWP的回顾性研究

2026-05-270
PRE
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)

544例t(6;9)/DEK::NUP214急性髓系白血病患者行异基因干细胞移植的结局:欧洲血液和骨髓移植组急性白血病工作组(ALWP)和儿科疾病工作组(PDWP)的代表性研究

2026-04-220
PRE
Outcomes of Salvage Therapy After Early-Line CD19 CAR-T Failure in Large B-Cell Lymphoma

大B细胞淋巴瘤中,CD19 CAR-T早期治疗失败后的挽救治疗效果

2026-04-040
PRE
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

外周血干细胞与骨髓移植物在含移植后环磷酰胺的非T细胞去除半相合移植治疗二次急性髓系白血病首次完全缓解患者中的比较:一项来自ALWP/EBMT的研究

2026-03-250
OAAI
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma

基于里程碑的CD19 CAR T细胞疗法后大型B细胞淋巴瘤的长期预后评估

2026-02-280
PRE
EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study

EASIX在CAR T细胞疗法中不增加超过乳酸脱氢酶和ECOG体力状态 prognostic value:一项GETH-TC研究

2026-01-010
PRE